Abstract
We have performed a study aimed at investigating the critical concentration of urinary cadmium (UCd) required for the development of renal dysfunction. We studied population groups (totally 790 persons) living in two cadmium exposed areas and one control area in China. UCd, was determined as an indicator of cadmium exposure and accumulation, while the concentrations of N-acetyl-β-D-glucosaminidase (NAG), its iso-form B (NAG-B), β2-microglobulin (B2M), retinol binding protein (RBP), and albumin (ALB) in urine were measured as indicators of the renal effects caused by cadmium. There was a significantly increased prevalence of hyperNAGuria, hyperNAG-Buria, hyperB2Muria, hyperRBPuria and hyperALBuria with increasing levels of Cd excretion in urine. We used the benchmark dose (BMD) procedure to estimate the critical concentration of urinary cadmium in this general population. The lower confidence limit of the BMD (LBMD-05) of urinary cadmium for a 5% level of risk above the background level was estimated for each of the renal effect indicators. The BMD-05/LBMD-05 were estimated to be 4.46/3.99, 6.70/5.87, 8.36/7.31, 7.98/6.98 and 15.06/12.18 μg/g creatinine for urinary NAG-B, NAG, B2M, RBP and ALB, respectively. Our findings suggest, based on the present study, that the Lower Confidence Limit of the Population Critical Concentration of UCd (LPCCUCd-05) of tubular dysfunction for 5% excess risk level above the background may be ca. 3–4 μg/g creatinine, and that cadmium concentration in urine should be kept below this level to prevent renal tubular damage. This report is the first to use the BMD method in this field and to define the concept of critical concentration in urine.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bernard A, Buchet JP, Roels H, Masson P, Lauwerys R. 1979 Renal excretion of proteins and enzymes in workers exposed to cadmium. Eur J Clin Invest9, 11–22.
Bernard A, Roels H, Buchet JP, Cardenas A, Lauwerys R. 1992 Cadmium and health: the Belgium experience (review). In: Nordberg GF, Herber RFM, Alessio L, eds. Cadmium in the Human Environment: Toxicity and Carcinogenicity. Lyon. France. TIIARC Scientific PublicationS,Vol.118, 15–33.
Bernard A, Thielemans N, Roels H, Lauwerys, R. 1995 Association between NAG-B and cadmium in urine with no evidence of a threshold. Occup Environ Med 52, 177–180.
Buchet JP, Lauwerys R, Roels H, Bernard A, Bruaux P, Claeys F. Ducoffre G, De Plaen P, Staessen J, Amery A. 1990 Renal effects of cadmium body burden of the general population. Lancet 336, 699–702.
Crump KS. 1984 A new method for determining allowable daily intakes. Fundam Appl Toxicol4, 854–871.
Crump KS, Howe RB. 1985 A review of methods for calculating confidence limits in low dose extrapolation. In: Krewski D, ed. Toxicology Risk Assessment. CRC Press, Canada.
Friberg L, Elinder CG, Kjellström T, Nordberg GF, eds. 1986 Cadmium and Health: A Toxicological and Epidemiological Appraisal, Vol. II. Boca Raton, FL, CRC Press.
Gaylor D, Ryan L, Krewski D, Zhu Y. 1998 Procedures for calcu-lation benchmark doses for health risk assessment. Regulatory Toxicology and Pharmarcology 28, 150–164.
Järup L, Berglund M, Elinder CG, Nordberg G, Vahter M. 1998 Health effects of cadmium exposure-a review of the literature and a risk estimate. Scand J Work Environ Health 24, suppl 1, 1–50.
Jin T, Nordberg GF, Wu X, Ye T, Kong Q, Wang Z, Zhuang F, Cai S. 1999 Urinary N-acetyl-â-D-glucosaminidase isoenzymes as biomarker of renal dysfunction caused by cadmium in a general population. Environ Res Section A 81, 167–173.
Jin T, Nordberg M, Frech W, Dumont X, Bernard A, Ye T, Kong Q, Wang Z, Li P, Lundstrom NG, Li Y, Nordberg G. 2002 Cad-mium biomonitoring and renal dysfunction among a population environmentally exposed to cadmium from smelting in China. Biometals 15, 397–410.
Kawada T, Koyama H, Suzuki S. 1989 Cadmium, NAG activity and â 2-microblobulin in the urine of cadmium pigment workers. Br J IndMed 46, 52–55.
Kimmel CA, Gaylor DW. 1988 Issues in qualitative and quantitative risk analysis for developmental toxicity. Risk Anal8, 15–20.
Kjellström T. 1986 Critical organs, critical concentrations, and whole body dose-response relationships. In: Friberg L, Elinder C, Kjellström T, Nordberg G, eds. Cadmium and Health: a toxic-ological and epidemiological appraisal. Vol. 2. Boca Raton, FL, USA CRC Press. 231–251.
Nogawa K, Yamada Y, Kido T, Honda R, Ishizaki M, Tsuritani I, Kobayashi E. 1986 Significance of elevated urinary N-acetyl-â-D-glucosaminidase activity in chronic cadmium poisoning. Sci Total Envir Res 48, 7–16.
Nogawa K, Kido T, Shaikh ZA. 1992 Dose-response relationship for renal dysfunction in a population environmentally exposed to cadmium. In: Nordberg GF, Herber RFM, Alessio L., Eds. Cadmium in the Human Environment: Toxicity and Carcino-genicity. IARC Scientific Publications, Vol. 118, Lyon. France. pp. 311–318.
Nordberg GF. 1992 Application of the 'critical effect' and 'critical concentration' concept to human risk assessment for cadmium. In: Nordberg GF, Herber RFM, Alessio L., eds, Cadmium in the Human Environment: Toxicity and Carcinogenicity. IARCiScientific Publications, Vol 118, Lyon. France. 3–14.
Nordberg GF. 1996 Current Issues in low-dose cadmium toxicology: Nephrotoxicity and Carcinogenicity. Environmental Sciences4, 133–147.
World Health Organization. WHO 1992 Environmental Health Cri-teria 134, Cadmium. Geneva.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Jin, T., Wu, X., Tang, Y. et al. Environmental epidemiological study and estimation of benchmark dose for renal dysfunction in a cadmium-polluted area in China. Biometals 17, 525–530 (2004). https://doi.org/10.1023/B:BIOM.0000045732.91261.e2
Issue Date:
DOI: https://doi.org/10.1023/B:BIOM.0000045732.91261.e2